Jamie Manning
Physician Assistant · Ionia, MINPI 1720414923
Payments from drug & device makers
Across 85 payments — averaging $18.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$371
- AstraZeneca$218
- Pfizer$136
- GSK$127
- Lilly USA, LLC$117
- Otsuka America Pharmaceutical, Inc.$77
- plus $487 from 15 others
What the payments were for
- Food & beverage$1,534100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $371 |
| AstraZeneca | 12 | $218 |
| Pfizer | 8 | $136 |
| GSK | 7 | $127 |
| Lilly USA, LLC | 7 | $117 |
| Otsuka America Pharmaceutical, Inc. | 4 | $77 |
| AbbVie | 4 | $70 |
| Amgen | 3 | $55 |
| Bayer | 3 | $49 |
| Viatris Specialty LLC | 2 | $44 |
| Merck | 2 | $42 |
| Phadia US Inc. | 3 | $42 |
| Mylan Specialty L.p. | 2 | $35 |
| Exact Sciences | 2 | $32 |
| Edwards Lifesciences | 1 | $27 |
| Corium, LLC | 1 | $19 |
| Boehringer Ingelheim | 1 | $16 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
| Alnylam Pharmaceuticals Inc. | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
How this compares
$1,534 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 67 | $70,805 |
| EliquisApixaban | 52 | $45,801 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $42,845 |
| JardianceEmpagliflozin | 23 | $32,987 |
| XareltoRivaroxaban | 17 | $14,382 |
| Atorvastatin Calcium | 226 | $3,856 |
| Wixela InhubFluticasone Propion/Salmeterol | 12 | $2,676 |
| Duloxetine Hcl | 64 | $2,448 |
| Lisinopril | 157 | $1,699 |
| Levothyroxine Sodium | 115 | $1,619 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 31 | $1,586 |
| Metoprolol Succinate | 52 | $1,468 |
| Amlodipine Besylate | 135 | $1,307 |
| Losartan Potassium | 64 | $1,279 |
| Potassium Chloride | 30 | $1,260 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $371 | $70,80567 claims |
| PfizerEliquis | $136 | $45,80152 claims |
| GSKTrelegy Ellipta | $127 | $42,84528 claims |
| Boehringer IngelheimJardiance | $16 | $32,98723 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.
Other physician assistant in Ionia
- Sarang PatelRoyal Oak$660K
- Beth SweneyAda$617K
- Zainab JishiCanton$596K
- Taylor HennrickAdrian$430K
- Erin van DykeGrand Rapids$346K
- Ashley AldridgeAnn Arbor$298K
- Derek SusallaRochester Hills$242K
- Gabrielle DamoreRoyal Oak$200K
- Melissa MickelsonKalamazoo$168K
- Patrick CooneyNew Baltimore$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.